
The IMID Forum
Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
Latest episodes

Jun 10, 2024 • 14min
EULAR 2024 Preview Podcast
Join Dr Sofia Ramiro, Professor Rieke Alten, and Associate Professor Laura Coates as they guide you through their top selections in RA, PsA, and axSpA at EULAR 2024, so that you can better plan your time at what will be a busy and exciting congress.

Jun 6, 2024 • 30min
Discussing RA: May 2024
Join Professor Janet Pope and Dr Sofia Ramiro on The IMID Forum as they discuss the long-term safety of JAK inhibitors in RA. They delve into papers comparing tofacitinib versus TNFi in cardiovascular risk and the efficacy of upadacitinib over five years. The podcast also explores the importance of proper treatment to reduce risks and the balancing act of benefits versus risks in JAK inhibitor prescriptions for inflammatory diseases.

May 14, 2024 • 23min
IMID Author Interview: Dorthe Berthelsen, 2024
Join Professor Peter Nash from the Griffith University in Brisbane, and Dorthe Berthelsen, a PhD student and physiotherapist at the Parker Institute in Copenhagen and at the University of Southern Denmark, as they discuss her recent paper ‘“I couldn't carry on taking a drug like that”: A qualitative study of patient perspectives on side effects from rheumatology drugs.’

May 7, 2024 • 30min
Webinar Highlights Podcast: Evolving Therapeutic Strategies for Psoriatic Diseases
Webinar Highlights Podcast: Join Professor Iain McInnes and Associate Professor Laura Coates on the Immune-Mediated Inflammatory Disease Forum in their discussion on the recent webinar “Evolving Therapeutic Strategies for Psoriatic Diseases: Not all IL-23s are Created Similar”. Watch them discuss key highlights from the webinar including the burden of PsA and PsO, the pathophysiology of IL-23 inhibitors compared with TNF and IL-17 inhibitor therapies, and the relationship between IL-23 inhibitor MOA variation and real-world patient data.

May 7, 2024 • 21min
IMID Author Interview: Dr Jake Weddell, 2024
Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Jake Weddell, an academic rheumatology trainee at Leeds Teaching Hospitals NHS Trust, as they discuss his recent paper ‘Real-world experience of IL-17Ai drug survival in a large cohort of axial spondyloarthritis and psoriatic arthritis.’

Apr 30, 2024 • 21min
IMID Author Interview: Professor Frank Verhoeven, 2024
Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Frank Verhoeven, an Assistant Professor in Rheumatology at the CHU Besancon in France, as they discuss his recent paper ‘Effects of disease‑modifying anti‑rheumatic drugs on sacroiliac MRI score in axial spondyloarthritis: A systematic review and meta‑analysis.’

Apr 25, 2024 • 11min
Discussing RA: April 2024
Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest information and data in RA. In this episode, he discusses two papers related to the long-term safety of JAK inhibitors compared to TNF inhibitors. In our first paper, Christina Charles-Schoeman and colleagues assessed the risk of venous thromboembolism in patients with RA initiating tofacitinib or TNFi. Our second paper is from Roy Fleischmann and colleagues compare the long-term efficacy and safety data of upadacitinib switched from adalimumab and in adalimumab switched from upadacitinib. To access detailed summary slides for the papers discussed today, visit imidforum.com.

Apr 18, 2024 • 22min
Author Interview: Professor Maria Antonietta D’Agostino, 2024
Join Professor Peter Nash from the Griffith University in Brisbane, and Maria Antonietta D’Agostino, the Head of the Rheumatology Department at the Catholic University of the Sacred Heart in Rome, as they discuss her recent paper 'Effects of Secukinumab on Synovitis and Enthesitis in Patients with Psoriatic Arthritis: 52-week Clinical and Ultrasound Results from the Randomised, Double-blind ULTIMATE Trial with Open Label Extension'.

Apr 16, 2024 • 31min
Author Interview: Professor Dennis McGonagle, 2024
Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Dennis McGonagle, a Clinical Professor at the University of Leeds School of Medicine, as they discuss his recent paper ‘Association of the Clinical Components in the Distal Interphalangeal Joint Synovio-entheseal Complex and Subsequent Response to Ixekizumab or Adalimumab in Psoriatic Arthritis.’

Apr 4, 2024 • 33min
Author Interview: Dr Jürgen Rech, 2024
Dr Jürgen Rech discusses inhibiting inflammation to prevent rheumatoid arthritis, early intervention strategies, efficacy of abatacept in delaying onset of RA, role of ACTPA antibodies, smoking as a risk factor, biomarkers, and treatment benefits lasting up to 24 months.